MY149620A - Amino quinazolines derivatives with blood platelet reducing properties - Google Patents
Amino quinazolines derivatives with blood platelet reducing propertiesInfo
- Publication number
- MY149620A MY149620A MYPI20092152A MYPI20092152A MY149620A MY 149620 A MY149620 A MY 149620A MY PI20092152 A MYPI20092152 A MY PI20092152A MY PI20092152 A MYPI20092152 A MY PI20092152A MY 149620 A MY149620 A MY 149620A
- Authority
- MY
- Malaysia
- Prior art keywords
- blood platelet
- reducing properties
- platelet reducing
- derivatives
- prodrugs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/84—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0623749.9A GB0623749D0 (en) | 2006-11-28 | 2006-11-28 | Substituted quinazolines |
Publications (1)
Publication Number | Publication Date |
---|---|
MY149620A true MY149620A (en) | 2013-09-13 |
Family
ID=37671459
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI20092152A MY149620A (en) | 2006-11-28 | 2007-11-19 | Amino quinazolines derivatives with blood platelet reducing properties |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP2097390A1 (fr) |
JP (1) | JP2010511031A (fr) |
KR (1) | KR20090089865A (fr) |
CN (1) | CN101558048B (fr) |
AR (1) | AR064003A1 (fr) |
AU (1) | AU2007327048B2 (fr) |
BR (1) | BRPI0719568A2 (fr) |
CA (1) | CA2670168A1 (fr) |
EA (1) | EA017139B1 (fr) |
GB (1) | GB0623749D0 (fr) |
IL (1) | IL198808A0 (fr) |
MX (1) | MX2009005578A (fr) |
MY (1) | MY149620A (fr) |
TW (1) | TW200829252A (fr) |
WO (1) | WO2008065445A1 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0822970D0 (en) * | 2008-12-17 | 2009-01-21 | Shire Llc | Process for the preparation of anagrelide and analogues |
GB201004495D0 (en) | 2010-03-18 | 2010-05-05 | Shire Llc | Subtituted quinazolines |
CN103254197A (zh) * | 2013-05-29 | 2013-08-21 | 黑龙江大学 | 一种盐酸阿那格雷的制备方法 |
EP3236967B1 (fr) | 2014-12-22 | 2019-10-16 | SUDA Pharmaceuticals Ltd | Prévention et traitement d'une maladie métastatique chez des patients atteints d'un cancer et souffrant de thrombocytose |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4146718A (en) * | 1978-04-10 | 1979-03-27 | Bristol-Myers Company | Alkyl 5,6-dichloro-3,4-dihydro-2(1h)-iminoquinazoline-3-acetate hydrohalides |
US6194420B1 (en) * | 1999-11-30 | 2001-02-27 | Roberts Laboratories Inc. | 2-amino-5,6-dichloro-3,4-dihydroquinazoline, its method of making and using and pharmaceutical compositions thereof |
DE10301105B4 (de) * | 2003-01-09 | 2005-11-24 | Chemisch-Pharmazeutisches Labor, Rolf Sachse Gmbh | Verwendung von 2-Amino-2H-chinazolin-Derivaten zur Behandlung von myeloproliferativen Erkrankungen, Bluthochdruck und Bronchodilation |
WO2004064841A1 (fr) * | 2003-01-23 | 2004-08-05 | Shire Holdings Ag | Formulation et methodes de traitement de la thrombocythemie |
US7700608B2 (en) * | 2004-08-04 | 2010-04-20 | Shire Holdings Ag | Quinazoline derivatives and their use in the treatment of thrombocythemia |
-
2006
- 2006-11-28 GB GBGB0623749.9A patent/GB0623749D0/en not_active Ceased
-
2007
- 2007-11-19 CA CA002670168A patent/CA2670168A1/fr not_active Abandoned
- 2007-11-19 MX MX2009005578A patent/MX2009005578A/es not_active Application Discontinuation
- 2007-11-19 EA EA200900742A patent/EA017139B1/ru not_active IP Right Cessation
- 2007-11-19 BR BRPI0719568-0A patent/BRPI0719568A2/pt not_active IP Right Cessation
- 2007-11-19 MY MYPI20092152A patent/MY149620A/en unknown
- 2007-11-19 AU AU2007327048A patent/AU2007327048B2/en not_active Ceased
- 2007-11-19 WO PCT/GB2007/050698 patent/WO2008065445A1/fr active Application Filing
- 2007-11-19 KR KR1020097011681A patent/KR20090089865A/ko not_active Application Discontinuation
- 2007-11-19 JP JP2009538793A patent/JP2010511031A/ja active Pending
- 2007-11-19 CN CN2007800442221A patent/CN101558048B/zh not_active Expired - Fee Related
- 2007-11-19 EP EP07824910A patent/EP2097390A1/fr not_active Withdrawn
- 2007-11-27 TW TW096145029A patent/TW200829252A/zh unknown
- 2007-11-28 AR ARP070105273A patent/AR064003A1/es unknown
-
2009
- 2009-05-19 IL IL198808A patent/IL198808A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
MX2009005578A (es) | 2009-07-29 |
CN101558048A (zh) | 2009-10-14 |
EA200900742A1 (ru) | 2010-08-30 |
AU2007327048B2 (en) | 2012-01-12 |
AR064003A1 (es) | 2009-03-04 |
TW200829252A (en) | 2008-07-16 |
BRPI0719568A2 (pt) | 2013-12-10 |
IL198808A0 (en) | 2010-02-17 |
EA017139B1 (ru) | 2012-10-30 |
JP2010511031A (ja) | 2010-04-08 |
WO2008065445A1 (fr) | 2008-06-05 |
CN101558048B (zh) | 2012-07-25 |
EP2097390A1 (fr) | 2009-09-09 |
CA2670168A1 (fr) | 2008-06-05 |
AU2007327048A1 (en) | 2008-06-05 |
GB0623749D0 (en) | 2007-01-10 |
KR20090089865A (ko) | 2009-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL300701I1 (fr) | ||
TNSN08283A1 (en) | Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use | |
EA201300556A1 (ru) | Аминоспиртзамещенные производные 2,3-дигидроимидазо[1,2-с] хиназолина, пригодные для лечения гиперпролиферативных нарушений и заболеваний, связанных с ангиогенезом | |
TN2009000137A1 (en) | Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis | |
WO2008033562A3 (fr) | Composés inhibiteurs de kinases | |
IL182218A0 (en) | Preparation and use of biphenyl-4-yl-carbonylamino and derivatives for the treatment of obesity | |
SG178591A1 (en) | Jak2 inhibitors and their use for the treatment of myeloproliferative diseases and cancer | |
MX2009003724A (es) | Derivados de 2-aminocarbonil-piridina. | |
WO2010111406A3 (fr) | Composés et leurs utilisations thérapeutiques | |
TW200736234A (en) | Chemical compounds | |
MX2010007523A (es) | Nuevos derivados de pirazolo[3,4-d]pirimidina como farmacos anticancer. | |
MX2007013624A (es) | Inhibidores de proteina cinasa. | |
MX2010007584A (es) | Inhibidores de proteina cinasa y uso de los mismos. | |
WO2008049855A3 (fr) | Nouveaux composés | |
WO2008052139A3 (fr) | Doxepine à dose ultrafaible, et ses procédés d'utilisation pour traiter des troubles du sommeil | |
MX2010003269A (es) | Derivados de pirrolotriazina utiles para tratar cancer a traves de la inhibicion de la aurora quinasa. | |
HK1093729A1 (en) | Substituted quinolones | |
MX2009005579A (es) | Quinazolinas sustituidas. | |
MY150745A (en) | Isoserine derivatives for use as coagulation factor ixa inhibitors | |
WO2006089664A3 (fr) | Imidazoles substitues par heterocyclylamide | |
WO2010121675A3 (fr) | Thiazolyl-benzimidazoles | |
MY149620A (en) | Amino quinazolines derivatives with blood platelet reducing properties | |
TW200738611A (en) | 9-Chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments | |
MX2008011020A (es) | Compuestos de receptor sigma. | |
WO2009138796A3 (fr) | Quinazolines substitués |